Anti-obesity Pharmacotherapy and Inflammation
Public ClinicalTrials.gov record NCT05756764. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Pilot Study of the Effect of Weight Loss by Pharmacotherapy on Chronic Pro-tumor Inflammatory Cells
Study identification
- NCT ID
- NCT05756764
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Louisiana State University Health Sciences Center in New Orleans
- Other
- Enrollment
- 30 participants
Conditions and interventions
Conditions
Interventions
- Semaglutide Drug
- Phentermine-Topiramate combination Drug
- Phentermine Drug
- Tirzepatide Drug
- Topiramate Drug
- Diethylpropion Drug
- Naltrexone/Bupropion Drug
- Liraglutide Drug
Drug
Eligibility (public fields only)
- Age range
- 35 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2023
- Primary completion
- Jan 29, 2026
- Completion
- Feb 19, 2026
- Last update posted
- Sep 8, 2025
2023 – 2026
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| LSU Clinical & Translational Research Center (CTRC - - LSUHSC-NO | New Orleans | Louisiana | 70112 | — |
| Ochsner Health System - Biospecimen | New Orleans | Louisiana | 70121 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05756764, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 8, 2025 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05756764 live on ClinicalTrials.gov.